Chronic rhinosinusitis with and without nasal polyps and asthma: Omalizumab improves residual anxiety but not depression

Chronic rhinosinusitis with and without nasal polyps and asthma: Omalizumab improves residual anxiety but not depression

Abstract Background Chronic rhinosinusitis (CRS) has a high prevalence of anxiety and depression. It is currently uncertain if treatment in patients with CRS with or without nasal polyps (CRSwNP and CRSsNP) has any impact on improving mental health outcomes. The aims here were to document anxiety an...

Full description

Bibliographic Details
Main Authors: Florian Vogt, Jagdeep Sahota, Therese Bidder, Rebecca Livingston, Helene Bellas, Simon B. Gane, Valerie J. Lund, Douglas S. Robinson, Harsha H. Kariyawasam
Format: Article
Language:English
Published: Wiley 2021-03-01
Series:Clinical and Translational Allergy
Subjects:
anxiety
asthma
depression
omalizumab
rhinosinusitis
Online Access:https://doi.org/10.1002/clt2.12002

Internet

https://doi.org/10.1002/clt2.12002

Similar Items